Short-term investors occasionally find a big win (like the short squeezes in meme stocks back in 2021 ... The company currently markets medicine for multiple myeloma, lymphoblastic leukemia ...

Multiple myeloma is a disease that most people haven’t heard of until it impacts their lives directly. This blood cancer can sound daunting but understanding it is the first step towards ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...

Her treatment consisted of rhubarb pills and an infusion of orange peels. Now, 181 years later, multiple myeloma remains incurable, with most patients eventually relapsing or developing treatment ...

Pieter Sonneveld, MD, PhD, chair of the Erasmus MC Cancer Institute, discussed the findings of a study modeling long-term progression-free survival (PFS) in patients with multiple myeloma (MM ...

Multiple myeloma forms in blood plasma cells within bone marrow, affecting 2000 Australians a year. About 1500 of those are ineligible for stem cell transplantation – the standard treatment.

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in ...

The test measures a spectrum of genomic alterations and can be used by ordering physicians to molecularly diagnose individuals who have or are at risk for multiple myeloma and inform therapeutic ...

Regeneron Pharmaceuticals has announced that the European Commission has conditionally approved Lynozyfic (linvoseltamab) for adults with relapsed and refractory multiple myeloma. This approval ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...